Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy
Purpose: to evaluate the efficacy of agent Hylomax-Сomod in the postoperative period of Laser Epithelial Keratomileusis (LASEK).Methods: In 60 eyes (30 patients) was performed excimer laser vision correction by LASEK. According to study patients were randomized into 2 groups. Patients of the Group I...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2014-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/178 |
| _version_ | 1797875581580214272 |
|---|---|
| author | S. A. Korotkich A. S. Shamkin |
| author_facet | S. A. Korotkich A. S. Shamkin |
| author_sort | S. A. Korotkich |
| collection | DOAJ |
| description | Purpose: to evaluate the efficacy of agent Hylomax-Сomod in the postoperative period of Laser Epithelial Keratomileusis (LASEK).Methods: In 60 eyes (30 patients) was performed excimer laser vision correction by LASEK. According to study patients were randomized into 2 groups. Patients of the Group I have been treated by the standard protocol of medical support. Patients of the Group II along with the standard regimen were recieved Hylomax-Сomod.Results: On the 2nd day after the excimer laser correction for 63.3% had patients of Group I had complete epithelialization of the ablation zone, the rest — a slight defect in the optical zone that recovered for 3-4 days. In Group II 80% of patients was determined by complete epithelialization of the ablation zone, the remaining 20% of patients went to a slight defect in the third day, which is 17% lower than that of patients in group I.Conclusion: Hylomax-Сomod promotes rapid healing of the ablation zone, reduce the risk of complications. |
| first_indexed | 2024-04-10T01:48:43Z |
| format | Article |
| id | doaj.art-5058c4bd9286452b81d30c4321441b54 |
| institution | Directory Open Access Journal |
| issn | 1816-5095 2500-0845 |
| language | Russian |
| last_indexed | 2024-04-10T01:48:43Z |
| publishDate | 2014-07-01 |
| publisher | Ophthalmology Publishing Group |
| record_format | Article |
| series | Oftalʹmologiâ |
| spelling | doaj.art-5058c4bd9286452b81d30c4321441b542023-03-13T09:08:35ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452014-07-0194656810.18008/1816-5095-2012-4-65-68178Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapyS. A. Korotkich0A. S. Shamkin1ГБОУ ВПО Уральская государственная медицинская академия Минздравсоцразвития России, ЕкатеринбургГБОУ ВПО Уральская государственная медицинская академия Минздравсоцразвития России, ЕкатеринбургPurpose: to evaluate the efficacy of agent Hylomax-Сomod in the postoperative period of Laser Epithelial Keratomileusis (LASEK).Methods: In 60 eyes (30 patients) was performed excimer laser vision correction by LASEK. According to study patients were randomized into 2 groups. Patients of the Group I have been treated by the standard protocol of medical support. Patients of the Group II along with the standard regimen were recieved Hylomax-Сomod.Results: On the 2nd day after the excimer laser correction for 63.3% had patients of Group I had complete epithelialization of the ablation zone, the rest — a slight defect in the optical zone that recovered for 3-4 days. In Group II 80% of patients was determined by complete epithelialization of the ablation zone, the remaining 20% of patients went to a slight defect in the third day, which is 17% lower than that of patients in group I.Conclusion: Hylomax-Сomod promotes rapid healing of the ablation zone, reduce the risk of complications.https://www.ophthalmojournal.com/opht/article/view/178лазерный эпистромальный кератомилезхиломакс-комодэпителизация роговицы |
| spellingShingle | S. A. Korotkich A. S. Shamkin Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy Oftalʹmologiâ лазерный эпистромальный кератомилез хиломакс-комод эпителизация роговицы |
| title | Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy |
| title_full | Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy |
| title_fullStr | Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy |
| title_full_unstemmed | Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy |
| title_short | Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy |
| title_sort | laser epithelial keratomileusis hylomax сomod as effective agent of accessory therapy |
| topic | лазерный эпистромальный кератомилез хиломакс-комод эпителизация роговицы |
| url | https://www.ophthalmojournal.com/opht/article/view/178 |
| work_keys_str_mv | AT sakorotkich laserepithelialkeratomileusishylomaxsomodaseffectiveagentofaccessorytherapy AT asshamkin laserepithelialkeratomileusishylomaxsomodaseffectiveagentofaccessorytherapy |